NEW YORK--(BUSINESS WIRE)--May 17, 2018--Flatiron Health today announced 11 abstracts accepted for presentation at the 2018 American Society for Clinical Oncology (ASCO) Annual Meeting, which will be held June 1-5 in Chicago. The research, spanning multiple tumor types and areas of study, utilized Flatiron's highly-curated, nationally-representative, real-world oncology datasets, the largest in the United States.

The research to be presented includes collaborations with the Abramson Cancer Center of the University of Pennsylvania, Fred Hutchinson Cancer Research Center, Genentech (a member of the Roche Group), Huntsman Cancer Institute at the University of Utah, the National Cancer Institute, Roche, the U.S. Food & Drug Administration, and Yale Cancer Center.

The presentation schedule and links to abstracts can be found below. To learn more about Flatiron Health, visit our booth #2049 during the conference or click here.

Oral Presentation

Presenting Author: Greg Riely (Memorial Sloan Kettering Cancer Center) Date/Time: 6/5/2018, 10:00 - 10:12 AM Abstract: #12006 Location: S406 Session: Tumor Biology

Poster Discussion Presentation

Presenting Author: Lotte Steuten (Fred Hutchinson Cancer Research Center) Date/Time: 6/2/2018, 4:45 - 6:00 PM Abstract: #6513 Poster: #339 Location: S102 Session: Health Services Research, Clinical Informatics, and Quality of Care

Poster Presentations (Location: Hall A)

Presenting Author: Ashwini Shewade (Genentech, a member of the Roche Group) Date/Time: 6/2/2018, 8:00 - 11:30 AM Abstract: #1037 Poster: #118 Session: Breast Cancer—Metastatic

Presenting Author: Carrie Bennette (Flatiron Health) Date/Time: 6/2/2018, 1:15 - 4:45 PM Abstract: #6537 Poster: #363 Session: Health Services Research, Clinical Informatics, and Quality of Care

Presenting Author: Jizu Zhi (U.S. Food & Drug Administration) Date/Time: 6/2/2018, 1:15 - 4:45 PM Abstract: #6553 Poster: #379 Session: Health Services Research, Clinical Informatics, and Quality of Care

Presenting Author: Kerin Adelson (Yale Cancer Center) Date/Time: 6/2/2018, 1:15 PM - 4:45 PM Abstract: #6590 Poster: #415 Session: Health Services Research, Clinical Informatics, and Quality of Care

Presenting Author: Michael W Lu (Genentech, a member of the Roche Group) Date/Time: 6/2/2018, 1:15 - 4:45 PM Abstract: #6578 Poster: #403 Session: Health Services Research, Clinical Informatics, and Quality of Care

Presenting Author: Stephen Bagley (Abramson Cancer Center of the University of Pennsylvania) Date/Time: 6/3/18, 8:00 - 11:30 AM Abstract: #9073 Poster: #396 Session: Lung Cancer—Non-Small Cell Metastatic

Presenting Author: Rebecca Miksad (Flatiron Health) Date/Time: 6/3/2018, 8:00 - 11:30 AM Abstract: #3613 Poster: #106 Session: Gastrointestinal (Colorectal) Cancer

Presenting Author: Susan Spillane (National Cancer Institute) Date/Time: 6/4/2018, 1:15 - 4:45 PM Abstract: #9569 Poster: #396 Session: Melanoma/Skin Cancers

Presenting Author: Shiven Patel (Huntsman Cancer Institute at the University of Utah) Date/Time: 6/4/2018, 1:15 - 4:45 PM Abstract: #10101 Poster: #89 Session: Patient and Survivor Care

About Flatiron

Flatiron Health is a healthcare technology and services company focused on accelerating cancer research and improving patient care. Our platform enables cancer researchers and care providers to learn from the experience of every patient. Currently, Flatiron partners with over 265 community cancer clinics, seven major academic research centers and the top 15 therapeutic oncology companies. For more information, please visit www.flatiron.com or follow us @FlatironHealth.

View source version on businesswire.com:https://www.businesswire.com/news/home/20180517005400/en/

CONTACT: Flatiron Health

Jenny Edelston, 707-395-7116

press@flatiron.com

KEYWORD: UNITED STATES NORTH AMERICA ILLINOIS NEW YORK

INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY CLINICAL TRIALS GENETICS ONCOLOGY RESEARCH FDA SCIENCE

SOURCE: Flatiron Health

Copyright Business Wire 2018.

PUB: 05/17/2018 09:00 AM/DISC: 05/17/2018 09:01 AM

http://www.businesswire.com/news/home/20180517005400/en